Pharma4L SRL
The score of Pharma4L shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +61 % Total assets +15 %
Accounts of the company itself (not consolidated).
The full file covers 9 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Pharma4L's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 31 Aug 2026
- Year ended 31 Dec 2024filed on 31 Oct 2025
- Year ended 31 Dec 2023filed on 30 Aug 2024
- Year ended 31 Dec 2022filed on 31 Aug 2023
- Year ended 31 Dec 2021filed on 22 Sep 2022
Pharma4L's financial analysis
- Solvency63.5%sector median: 55.6%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Pharma4L
Pharma4L's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0658.939.608
- VAT number
- BE0658939608
- Peppol
- Registered · 0208:0658939608 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 12 Jul 2016
- Registered office
- 9900 Eeklo
- Latest accounts
- 2025 · filed on 31 Aug 2026
- Activity
- Activities of holding companies (NACE 64210)
Pharma4L (SRL) has been based in Eeklo since 2016, active in: activities of holding companies. For 2025, it reports a net profit of 242,951 € and equity of €1.36m; its revenue is not published. Its solvency stands at 63.5%, above the median of its sector (55.6%).
Companies similar to Pharma4L
Companies in the same business, of comparable size and area, outside its group.
- HSL Holding Activities of holding companies Pelt · balance sheet €2.14m
- Sophie Coorevits Activities of holding companies Jabbeke · balance sheet €2.14m
- Milben Holding Activities of holding companies Lanaken · balance sheet €2.14m
- Belemo Activities of holding companies Izegem · balance sheet €2.14m
- MVO Invest Activities of holding companies Zedelgem · balance sheet €2.14m
- Passiflora Activities of holding companies Huldenberg · balance sheet €2.14m
- Carpentier Invest Activities of holding companies Tielt · balance sheet €2.13m
- ShipCo Activities of holding companies Bruges · balance sheet €2.13m
Frequently asked questions about Pharma4L
What is the revenue of Pharma4L?
Pharma4L files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Pharma4L?
In Belgium, the VAT number is the company number prefixed with BE: BE0658939608 for Pharma4L, if the company is VAT-registered. Its company number (CBE) is 0658.939.608.
Where is the registered office of Pharma4L?
According to the CBE register, the registered office of Pharma4L is in 9900 Eeklo.
What is the equity of Pharma4L?
At the close of the 2025 financial year, the equity of Pharma4L amounts to 1,356,264 €, a solvency of 63.5% of total assets.
Who manages Pharma4L?
The register lists 1 active mandates at Pharma4L. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Pharma4L
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →